Claire Thomas
Directeur/Bestuurslid bij REBUS HOLDINGS, INC.
Vermogen: - $ op 31-12-2023
Oorsprong van het eerstegraads netwerk van Claire Thomas
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.
20
| Subsidiary | Pharmaceuticals: Major | 20 |
| Public Company | Biotechnology | 13 | |
| Public Company | Pharmaceuticals: Major | 11 | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Claire Thomas via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chairman Public Communications Contact | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KURA ONCOLOGY, INC. | Biotechnology | Founder Chief Operating Officer | |
| University of Virginia | College/University | Doctorate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MARUI GROUP CO., LTD. | Finance/Rental/Leasing | Director/Board Member | |
| SEPTENI HOLDINGS CO., LTD. | Advertising/Marketing Services | Director/Board Member | |
| BLUEBIRD BIO, INC. | Biotechnology | Investor Relations Contact | |
HuBit Genomix KK
 HuBit Genomix KK Miscellaneous Commercial ServicesCommercial Services HuBit Genomix KK is a Japanese pharmaceutical development company that conducts clinical trials and research on pharmaceuticals to develop diagnostic drugs. The company is based in Tokyo, Japan. The company analyzes and utilize valuable information to create "diagnosis methods" and "pharmaceuticals" that satisfy medical amenities. HuBit Genomix KK was acquired by Celera Group on March 20, 2001. | Miscellaneous Commercial Services | President | |
| Keio University | College/University | Doctorate Degree Graduate Degree | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Vermont | College/University | Undergraduate Degree Undergraduate Degree | |
| Wesleyan University | College/University | Undergraduate Degree Undergraduate Degree | |
Monsanto Japan Ltd.
 Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The company is based in Tokyo, Japan. | Chemicals: Agricultural | President | |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Chief Investment Officer | |
| University of Tokyo | College/University | Undergraduate Degree Doctorate Degree | |
International Certificate Authority of Management System
 International Certificate Authority of Management System Miscellaneous Commercial ServicesCommercial Services Part of Shield Group Holdings, Inc., International Certificate Authority of Management System is a certification organization specializing in information security. Based in Tokyo, Japan, ICMS has a track record in the number one class for PCI DSS audits and ISMS cloud security. The Japanese company provides audit services for network components, servers, applications, organizations, and operations connected to all card members' data environments. ICMS also offers information security measures and Wi-Fi diagnostic services, with a team of experts available for consultation. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| LINK AND MOTIVATION INC. | Personnel Services | Director/Board Member | |
| EPIZYME, INC. | Biotechnology | Investor Relations Contact Chief Operating Officer | |
| University of Tsukuba | College/University | Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Globis Corp.
 Globis Corp. Investment ManagersFinance Globis Corp. (Globis) is an independent venture capital firm headquartered in Tokyo, Japan. The firm was founded in 1992 by Hori Yoshito. | Investment Managers | President | |
Life Science Management, Inc.
 Life Science Management, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Management, Inc. provides consulting services for businesses in the life science and healthcare industries. The Japanese company's focus is on helping these businesses to succeed and grow. | Miscellaneous Commercial Services | President | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| Boston University School of Law | College/University | Graduate Degree Graduate Degree | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| EUGLENA CO., LTD. | Pharmaceuticals: Other | Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
ProNova Inc.
 ProNova Inc. Personnel ServicesCommercial Services ProNova Inc. is a management consulting Japanese company founded by Etsuko Okajima, who has been the CEO since its inception. The company's mission is to create professional management and strengthen the Japanese management team through organizational development consulting, leadership development, and next-generation managers. | Personnel Services | Founder | |
| KAMAKURA SHINSHO, LTD. | Commercial Printing/Forms | Director/Board Member | |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
Braizon Therapeutics, Inc.
 Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Braizon Therapeutics, Inc. is a Japanese company that engages in researching and developing drugs. The company was founded in 2015 by Mariko Tosu. The CEO is Bunichi Wanibuchi. | Miscellaneous Commercial Services | Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Founder Founder | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Chairman Director/Board Member | |
Tome Biosciences, Inc.
 Tome Biosciences, Inc. BiotechnologyHealth Technology Tome Biosciences, Inc. provides genomic medicine insertion and technologies services. The company is based in Cambridge, MA. The CEO of the company is Rahul Kakkar. | Biotechnology | Director/Board Member | |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| ALKERMES PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer |
Statistieken
Internationaal
| Verenigde Staten | 30 |
| Japan | 20 |
| Verenigd Koninkrijk | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 16 |
| Commercial Services | 11 |
| Finance | 4 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 198 |
| Corporate Officer/Principal | 95 |
| Independent Dir/Board Member | 69 |
| Chief Tech/Sci/R&D Officer | 36 |
| Undergraduate Degree | 33 |
Sterkste connecties
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jeffrey Leiden | 43 |
| Bo Jesper Hansen | 34 |
| Christopher Lowe | 25 |
| Scott Ogilvie | 21 |
| Hiromichi Kimura | 16 |
| Nancy Simonian | 16 |
| Santhosh Palani | 14 |
| Marsha Fanucci | 13 |
| Peter E. Grebow | 12 |
| Etsuko Okajima | 12 |
| Jerald Korn | 10 |
| Hikaru Saito | 10 |
| Susan Moran | 10 |
| Daniel Curran | 10 |
- Beurs
- Insiders
- Claire Thomas
- Bedrijfsconnecties
